Comparative study between global pharmaceutical company and public institution of production and innovation in health

Abstract

The technological scenario in the field of health is an alarming fact, especially in the context caused by  COVID-19. In this context, the Oswaldo Cruz  Foundation, through the Bio-Manguinhos Unit, and  the Butantan Institute were protagonists for universal  access, dialoguing with international strategies. This article, methodologically developed  through qualitative descriptive research,  bibliographical, documentary and field work, sought  to trace symmetries and asymmetries based on the  experiences collected in a global pharmaceutical  company and a public national reference institution in the field of technological incorporation in health. As a  result, key points are explained for the technical and  political strengthening of the Health Economic- Industrial Complex, through the organizational review  of the IPPIS regarding innovation and management  aspects, culminating in the promotion of  improvements in the science, technology and  innovation policy in response to the challenge of  sustainability, effectiveness and access in the SUS.